Table T2_3_1_1-1_2a

2012 National Healthcare Quality and Disparities Reports

This appendix provides detailed data tables for all measures analyzed for the 2012 National Healthcare Quality and Disparities Reports. Tables are included for measures discussed in the main text of the reports as well as for other measures that were examined but not included in the main text.
Table 2_3_1_1.1_2a
End stage renal disease patients age 18 and over who saw a nephrologist at least 12 months prior to initiation of renal replacement therapy,a by race, United States, 2009
  TotalWhiteBlackAsianAI/AN
Population groupPercentSEPercentSEPercentSEPercentSEPercentSE
Total 28.30.129.80.224.80.327.70.7DNADNA
Age18–4423.40.426.40.518.90.626.21.7DNADNA
45–6427.20.228.70.324.60.427.31.1DNADNA
65 and over30.40.231.20.328.10.528.41.0DNADNA
GenderMale28.00.229.70.223.70.427.10.9DNADNA
Female28.60.229.90.326.10.428.31.0DNADNA

a Denominator includes all incident end stage renal disease patients age 18 and over with valid CMS-2728 Medical Evidence form, and a nonmissing value for the question: Did you see a nephrologist at all? Numerator includes those who saw a nephrologist at least 12 months prior to initiation of renal replacement therapy.

DNA - Data have not been analyzed.

Key: AI/AN: American Indian/Alaska Native; SE: standard error.

Source: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, United States Renal Data System.

Page last reviewed June 2013
Internet Citation: Table T2_3_1_1-1_2a: 2012 National Healthcare Quality and Disparities Reports. June 2013. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/research/findings/nhqrdr/nhqrdr12/3_chronickidneydisease/T2_3_1_1-1_2a.html